Prednisolon Behandling Ved Akut Interstitiel Nefritis - et Randomiseret, Prospektivt Studie
Who is this study for? Patients with Acute Tubulo-Interstitial Nephritis
What treatments are being studied? Prednisone
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Biopsy verified AIN
• Clinical suspicion of AIN
• Age \> 18 years
• One of following criteria:
‣ Plasma creatinine \> 120 µmol/L or
⁃ Plasma creatinine increase \> 30 µmol/L or increase \> 50 % of baseline plasma creatinine
• Fertile women are included
Locations
Other Locations
Denmark
Godstrup Hospital
RECRUITING
Herning
Contact Information
Primary
Frank Mose, MD
frchri@rm.dk
+4528531257
Time Frame
Start Date: 2017-09-01
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 110
Treatments
No_intervention: Control
No treatment
Active_comparator: Prednisone
Oral prednisone. Starting dose of 60 mg with tapering for 2 months
Related Therapeutic Areas
Sponsors
Leads: Region MidtJylland Denmark
Collaborators: Odense University Hospital, Aarhus University Hospital